Responses to liposomal doxorubicin, bevacizumab, and temsirolimus in metaplastic carcinoma of the breast: Biologic rationale and implications for stem-cell research in breast cancer

Stacy Moulder; John Moroney; Thorunn Helgason; Jennifer Wheler; Daniel Booser; Constance Albarracin; Phuong K. Morrow; Kimberly Koenig; Razelle Kurzrock

doi:10.1200/JCO.2010.34.0604

Responses to liposomal doxorubicin, bevacizumab, and temsirolimus in metaplastic carcinoma of the breast: Biologic rationale and implications for stem-cell research in breast cancer

Stacy Moulder, John Moroney, Thorunn Helgason, Jennifer Wheler, Daniel Booser, Constance Albarracin, Phuong K. Morrow, Kimberly Koenig, Razelle Kurzrock

Research output: Contribution to journal › Article › peer-review

61 Scopus citations

Original language	English (US)
Pages (from-to)	e572-e575
Journal	Journal of Clinical Oncology
Volume	29
Issue number	19
DOIs	https://doi.org/10.1200/JCO.2010.34.0604
State	Published - Jul 1 2011

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1200/JCO.2010.34.0604

Cite this

Moulder, S., Moroney, J., Helgason, T., Wheler, J., Booser, D., Albarracin, C., Morrow, P. K., Koenig, K., & Kurzrock, R. (2011). Responses to liposomal doxorubicin, bevacizumab, and temsirolimus in metaplastic carcinoma of the breast: Biologic rationale and implications for stem-cell research in breast cancer. Journal of Clinical Oncology, 29(19), e572-e575. https://doi.org/10.1200/JCO.2010.34.0604

Responses to liposomal doxorubicin, bevacizumab, and temsirolimus in metaplastic carcinoma of the breast: Biologic rationale and implications for stem-cell research in breast cancer. / Moulder, Stacy; Moroney, John; Helgason, Thorunn et al.
In: Journal of Clinical Oncology, Vol. 29, No. 19, 01.07.2011, p. e572-e575.

Research output: Contribution to journal › Article › peer-review

Moulder, S, Moroney, J, Helgason, T, Wheler, J, Booser, D , Albarracin, C, Morrow, PK, Koenig, K & Kurzrock, R 2011, 'Responses to liposomal doxorubicin, bevacizumab, and temsirolimus in metaplastic carcinoma of the breast: Biologic rationale and implications for stem-cell research in breast cancer', Journal of Clinical Oncology, vol. 29, no. 19, pp. e572-e575. https://doi.org/10.1200/JCO.2010.34.0604

@article{7103509cc73b42c684c2b3c6606725c4,

title = "Responses to liposomal doxorubicin, bevacizumab, and temsirolimus in metaplastic carcinoma of the breast: Biologic rationale and implications for stem-cell research in breast cancer",

author = "Stacy Moulder and John Moroney and Thorunn Helgason and Jennifer Wheler and Daniel Booser and Constance Albarracin and Morrow, {Phuong K.} and Kimberly Koenig and Razelle Kurzrock",

year = "2011",

month = jul,

day = "1",

doi = "10.1200/JCO.2010.34.0604",

language = "English (US)",

volume = "29",

pages = "e572--e575",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "American Society of Clinical Oncology",

number = "19",

}

TY - JOUR

T1 - Responses to liposomal doxorubicin, bevacizumab, and temsirolimus in metaplastic carcinoma of the breast

T2 - Biologic rationale and implications for stem-cell research in breast cancer

AU - Moulder, Stacy

AU - Moroney, John

AU - Helgason, Thorunn

AU - Wheler, Jennifer

AU - Booser, Daniel

AU - Albarracin, Constance

AU - Morrow, Phuong K.

AU - Koenig, Kimberly

AU - Kurzrock, Razelle

PY - 2011/7/1

Y1 - 2011/7/1

UR - http://www.scopus.com/inward/record.url?scp=79960127513&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79960127513&partnerID=8YFLogxK

U2 - 10.1200/JCO.2010.34.0604

DO - 10.1200/JCO.2010.34.0604

M3 - Article

C2 - 21482991

AN - SCOPUS:79960127513

SN - 0732-183X

VL - 29

SP - e572-e575

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

IS - 19

ER -

Responses to liposomal doxorubicin, bevacizumab, and temsirolimus in metaplastic carcinoma of the breast: Biologic rationale and implications for stem-cell research in breast cancer

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this